Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: A multicenter, open-label study

被引：29

作者：

Snydman, DR

Falagas, ME

Avery, R

Perlino, C

Ruthazer, R

Freeman, R

Rohrer, R

Fairchild, R

O'Rourke, E

Hibberd, P

Werner, BG

机构：

[1] New England Med Ctr, Boston, MA 02111 USA

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[4] Emory Univ, Atlanta, GA 30322 USA

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

[6] Childrens Hosp, Boston, MA 02115 USA

[7] Harvard Univ, Sch Med, Boston, MA USA

[8] Massachusetts State Lib Inst, Boston, MA USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 04期

关键词：

D O I：

10.1016/S0041-1345(01)02101-7

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2571 / 2575

页数：5

共 22 条

[11]

MARTIN M, 1994, TRANSPLANTATION, V58, P779

[12] Cytomegalovirus prophylaxis in solid organ transplant recipients [J].

Patel, R ;

Snydman, DR ;

Rubin, RH ;

Ho, M ;

Pescovitz, M ;

Martin, M ;

Paya, CV .

TRANSPLANTATION, 1996, 61 (09) :1279-1289

[13] RISK-FACTORS FOR CYTOMEGALOVIRUS AND SEVERE BACTERIAL-INFECTIONS FOLLOWING LIVER-TRANSPLANTATION - A PROSPECTIVE MULTIVARIATE TIME-DEPENDENT ANALYSIS [J].

PAYA, CV ;

WIESNER, RH ;

HERMANS, PE ;

LARSONKELLER, JJ ;

ILSTRUP, DM ;

KROM, RAF ;

RETTKE, S ;

SMITH, TF .

JOURNAL OF HEPATOLOGY, 1993, 18 (02) :185-195

[14] Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation [J].

Rosen, HR ;

Benner, KG ;

Flora, KD ;

Rabkin, JM ;

Orloff, SL ;

Olyaei, A ;

Chou, SW .

TRANSPLANTATION, 1997, 63 (03) :476-478

[15] COMBINED ANTIBODY AND GANCICLOVIR TREATMENT OF MURINE CYTOMEGALOVIRUS-INFECTED NORMAL AND IMMUNOSUPPRESSED BALB/C MICE [J].

RUBIN, RH ;

LYNCH, P ;

PASTERNACK, MS ;

SCHOENFELD, D ;

MEDEARIS, DN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) :1975-1979

[16]

SAS Institute Inc, 1990, SAS STAT US GUID VER

[17] Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors [J].

Seu, P ;

Winston, DJ ;

Holt, CD ;

Kaldas, F ;

Busuttil, RW .

TRANSPLANTATION, 1997, 64 (11) :1614-1617

[18] HIGH-DOSE ACYCLOVIR COMPARED WITH SHORT-COURSE PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS - A RANDOMIZED TRIAL [J].

SINGH, N ;

YU, VL ;

MIELES, L ;

WAGENER, MM ;

MINER, RC ;

GAYOWSKI, T .

ANNALS OF INTERNAL MEDICINE, 1994, 120 (05) :375-381

[19]

SNYDMAN DR, 1991, TRANSPLANT P, V23, P1357

[20]

SNYDMAN DR, 1993, ANN INTERN MED, V119, P98

← 1 2 3 →